Recent Research Articles
According to a new study published in the Journal of Oncology, breast cancer patients treated in facilities offering integrative medicine support had better survival outcomes than patients treated in facilities that did not offer complementary treatment options.
Brown rice contains more inorganic arsenic than white rice. A new study reveals how to easily reduce the cumulative effect of inorganic arsenic for brown rice lovers around the planet.
MD Anderson’s integrative medicine chief Dr. Lorenzo Cohen shares critical insights on the troubling environmental stew we live in, what we know about its impact on cancer, and how best to limit our exposure.
Despite the remarkable progress in drug development across several populations of cancer, troubling facts have recently emerged about several expensive FDA-approved anticancer drugs.
Over the years I’ve coached many people who were determined to forego conventional cancer care—going against their oncologists’ recommendations, and often countering their partners’ and families’ opinions, too.
A recent investigation commissioned by the Environmental Working Group identified imazalil and thiabendazole on nearly 90 percent of non-organic citrus fruit samples.
Recent studies show approximately one in four blood cancer patients fail to produce detectable antibodies after COVID-19 vaccination. This is most prevalent in those hosting non-Hodgkin lymphomas and chronic lymphocytic leukemia, but also in those hosting multiple myeloma and other blood cancers.
Glenn Sabin explores the science on cancer causation and overall health impacts between conventional feedlot versus organic and wild red meat.
A cancer prevention moonshot is nowhere on the horizon. Cancer is given chance after chance after chance. The worst part? Cancer is an insatiable opportunist.
We met, in 1992, after my local hematologist had the presence of mind to send me to an academic expert for a second opinion. At the time, Lee was considered one of the country’s top physician-investigator experts for CLL, and had recently made full professor at Harvard Medical School—a rarity for a 43-year-old.